Hot Features
Premium
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Zeitraum:
Zeichenmodus:
| Volumen | 12.342 |
|
|||||
| News | - | ||||||
| Tageshoch | 1,6745 | Niedrig Hoch |
|||||
| Tagestief | 1,57 | ||||||
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| Oragenics Inc | OGEN | AMEX | Common Stock |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| -0,04 | -2,47% | 1,58 | 21:31:45 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 1,59 | 1,57 | 1,6745 | 1,62 |
| Trades | Volumen | VWAP | Finanzielles Volumen | Durchsch. Volumen | 52 Week Range |
|---|---|---|---|---|---|
| 158 | 12.342 | US$ 1,61 | US$ 19.892 | - | 1,00 - 7,74 |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| 21:33:52 | 79 | US$ 1,55 | USD |
Finanzwerte OGEN
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| 0 | 2,57M | - | 38k | -20,66M | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Oragenics
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 23.5.2024 | 15:27 | Edgar (US Regulatory) | Form 8-K - Current report |
| 22.5.2024 | 14:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 22.5.2024 | 14:00 | GlobeNewswire Inc. | Oragenics Appoints William “Frank” Peacock MD as Chief.. |
| 17.5.2024 | 14:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 17.5.2024 | 14:00 | GlobeNewswire Inc. | Oragenics, Inc. to Host Webinar Panel on Neurotrauma.. |
| 16.5.2024 | 14:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 16.5.2024 | 14:00 | GlobeNewswire Inc. | Oragenics, Inc. Prepares Intranasal Pharmaceutical, ONP-002,.. |
| 15.5.2024 | 19:00 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 07.5.2024 | 14:14 | Edgar (US Regulatory) | Form 8-K - Current report |
| 07.5.2024 | 14:00 | GlobeNewswire Inc. | Oragenics Partners with Avance Clinical for Phase II.. |
| 19.4.2024 | 23:50 | Business Wire | Oragenics, Inc. Announces Notification of Noncompliance with.. |
| 01.4.2024 | 15:05 | Business Wire | Oragenics, Inc. Files 10K and Provides Company Update |
Forum Oragenics
Keine Diskussionen Gefunden.Neuen Thread Erstellen
OGEN Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 1,73 | 2,02 | 1,523 | 1,70 | 26.326 | -0,15 | -8,67% |
| 1 Monat | 3,10 | 3,20 | 1,50 | 2,39 | 81.388 | -1,52 | -49,03% |
| 3 Monate | 1,45 | 3,43 | 1,00 | 2,01 | 112.968 | 0,13 | 8,97% |
| 6 Monate | 5,20 | 7,74 | 1,00 | 2,09 | 94.630 | -3,62 | -69,62% |
| 1 Jahr | 3,00 | 7,74 | 1,00 | 2,27 | 54.328 | -1,42 | -47,33% |
| 3 Jahre | 44,076 | 69,00 | 1,00 | 36,89 | 1.033.316 | -42,50 | -96,42% |
| 5 Jahre | 30,288 | 127,20 | 1,00 | 49,81 | 3.059.782 | -28,71 | -94,78% |
